Prostate Cancer Cure Rates
Version 2.0 of Prostate Cancer Risk Calculator Online
Diagnostic and prognostic potential of the proteomic profiling of serum-derived extracellular vesicles in prostate cancer | Cell Death & Disease
Interrogating Metastatic Prostate Cancer Treatment Switch Decisions: A Multi-institutional Survey - European Urology Focus
Frontiers | Predicting Cancer-Specific Survival Among Patients With Prostate Cancer After Radical Prostatectomy Based on the Competing Risk Model: Population-Based Study
Frontiers | Development of a web-based calculator to predict three-month mortality among patients with bone metastases from cancer of unknown primary: An internally and externally validated study using machine-learning techniques
Prediction of the “real” risk of death from prostate cancer | THE "NEW" PROSTATE CANCER INFOLINK
Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
FAQs About Prostate Cancer That Has Spread to the Bones | Everyday Health
Prediction of Prostate Cancer: External Validation of the ERSPC Risk Calculator in a Contemporary Dutch Clinical Cohort - European Urology Focus
Development and validation of a survival nomogram and calculator for male patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate and/or enzalutamide | BMC Cancer | Full Text
Prostate cancer - Wikipedia
Prostate Cancer Diagnosis and Staging: Practice Essentials, Overview, Relevant Anatomy
Metastatic Prostate Cancer Prognosis Calculator
CAPRA-S scores and projection of prostate cancer recurrence post-surgery | THE "NEW" PROSTATE CANCER INFOLINK
Predicting Life Expectancy in Men Diagnosed with Prostate Cancer - ScienceDirect
JPM | Free Full-Text | A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy
Estimation of life expectancy for newly diagnosed men with prostate cancer | THE "NEW" PROSTATE CANCER INFOLINK
Development and validation of a survival nomogram and calculator for male patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate and/or enzalutamide | BMC Cancer | Full Text
Metastatic Prostate Cancer: The PSA Screening Debate - Life Extension
Improving Disease Prognostics - Cambridge Prostate Cancer - facilitating world class research, diagnostics and care
Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study - The Lancet Oncology
Kaiser Permanente researchers develop new prostate cancer risk calculator – NCAL Research Spotlight
Diagnostic and prognostic factors in patients with prostate cancer: a systematic review protocol | BMJ Open
Tool helps predict who will respond best to targeted prostate cancer therapy | UCLA
